HealthDay.com
Aromatase Inhibitors Won’t Raise Odds of Most Fatal CVD Events
But there is a slightly increased risk of less serious cardiovascular issues
Ustekinumab More Effective Than TNF-α Inhibitors in Psoriasis
Ustekinumab more effective than three tumor necrosis factor-α-inhibitors at six, 12 months
Antimicrobial Treatment No Benefit After Kidney Transplant
Systematic antimicrobial tx of asymptomatic bacteriuria beyond 2 months post-transplant no help
How One Health System Is Shifting From Volume to Value
Health system provides continuum of care to underserved populations; providing help for doctors
Two Scales Correlate in Assessing Facial Paralysis
Good agreement, ease of use might sway adoption of the digitally graded scale
Lipid Tx Cuts Cardiovascular Risk with Type 1 Diabetes
Treatment important for primary prevention even without CVD history
CT CAP Rarely Reveals Acute Injury in Low-Velocity Trauma
Findings in low-velocity trauma patients without evidence of bodily harm
Ideal BP in Elderly With Chronic Kidney Disease Unclear
More cautious strategy for lowering blood pressure may be advisable in elderly patients with CKD
Dietary Polyphenols Don’t Provide Much CV Benefit in Metabolic Sx
Findings from review assessing supplementation in metabolic syndrome patients
American Association for Cancer Research, April 16-20
The American Association for Cancer Research Annual Meeting The annual meeting of the American Association for Cancer Research was held from April 16...
